Description
To prevent late-stage attrition in clinical trials, our In Silico ADMET Prediction service provides early, accurate evaluations of candidate drug-likeness. We utilize robust quantitative structure-activity relationship (QSAR) models and machine learning classifiers to assess a molecule's Absorption, Distribution, Metabolism, Excretion, and Toxicity parameters. From blood-brain barrier permeability and CYP450 inhibition to hERG toxicity profiling, our comprehensive simulations give developers critical data to refine molecular chemistry for optimal safety profiles.